1-3 of 3
Agnes van Horssen-Zoetbrood
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Aberrant Expression in Human Epithelial Cancers of the P2X5-Encoded Minor Histocompatibility Antigen LRH-1: Implications for Graft-Versus-Tumor Immunity Against Solid Tumors.

Harry Dolstra, PhD, Henriette Levenga, MD, Ingrid Overes, MSc, Johanna C.M. Vos, BSc, Agnes van Horssen-Zoetbrood, BSc, Robbert van der Voort, PhD, Pieter de Mulder, MD, PhD, T.M. de Witte, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1795.
https://doi.org/10.1182/blood.V110.11.1795.1795
Published: 2007
Journal Articles

Use of RNA Electroporated DC for Activation of LRH-1 Specific Cytotoxic T Lymphocytes in the Treatment of Lymphoid Malignancies.

Ingrid Overes, Hanny Fredrix, Bjorn de Rijke, Agnes van Horssen-Zoetbrood, Han van Krieken, Reinier Raymakers, Robbert van der Voort, T.M. de Witte, Harry Dolstra
Journal: Blood
Blood (2006) 108 (11): 138.
https://doi.org/10.1182/blood.V108.11.138.138
Published: 2006
Journal Articles

Human CD34+ Myeloid Leukemic Progenitor Cells Are Susceptible to Lysis by Minor Histocompatibility Antigen LRH-1-Specific Cytotoxic T Lymphocytes.

Harry Dolstra, PhD, Ingrid Overes, Inge Jedema, PhD, Annemieke Vos, Agnes van Horssen-Zoetbrood, Wieger Norde, Robbert van der Voort, PhD, J.H. Frederik Falkenburg, MD, PhD, Anton V. Schattenberg, MD, PhD, T.M. de Witte, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 134.
https://doi.org/10.1182/blood.V108.11.134.134
Published: 2006